Most Popular Stories
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
- Chelsea shares nosedive on FDA's questions about key drug
- Ben Venue can't say when crucial cancer drug will be available
- GSK studies Chinese remedies to discover new drugs
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
Webinars
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Featured Jobs
-
Director, Global Regulatory CMC Job
Celgene Corporation - Basking Ridge, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ
Events
- DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - Just Released: New Trends in Preventive and Therapeutic Vaccine
- Pharmaceutical Strategic Outlook
April 11-13, 2012
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- Pharma 2.0: Heading Toward Social Media Marketing
- Avoiding Post-Acquisition Product Sales Failures
- Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector
- Let travelers smell your rich media content
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
AtheroGenics CEO Russell M. Medford
